Financials Revenio Group Oyj

Equities

REG1V

FI0009010912

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Helsinki 11:29:46 2024-04-29 am EDT After market 02:00:23 pm
25.96 EUR +2.93% Intraday chart for Revenio Group Oyj 25.96 0.00%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 695.4 1,334 1,476 1,026 722.3 670.7 - -
Enterprise Value (EV) 1 699.2 1,332 1,475 1,014 719.5 652.9 632.5 615.7
P/E ratio 144 x 99.8 x 85.2 x 47.2 x 37.8 x 32 x 25 x 20.8 x
Yield 1.14% 0.64% 0.61% 0.93% 1.4% 1.59% 1.88% 2.26%
Capitalization / Revenue 14 x 21.8 x 18.7 x 10.6 x 7.48 x 6.39 x 5.62 x 4.91 x
EV / Revenue 14.1 x 21.8 x 18.7 x 10.5 x 7.45 x 6.22 x 5.3 x 4.51 x
EV / EBITDA 47.9 x 61.4 x 55.9 x 30.6 x 23 x 20.3 x 15.9 x 13.1 x
EV / FCF -12.5 x 104 x 184 x 48.1 x 147 x 27.5 x 22.5 x 19.2 x
FCF Yield -7.98% 0.96% 0.54% 2.08% 0.68% 3.63% 4.44% 5.21%
Price to Book 10.8 x 19.3 x 18.9 x 11.3 x 7.26 x 6.07 x 5.3 x 4.57 x
Nbr of stocks (in thousands) 26,492 26,528 26,563 26,580 26,593 26,593 - -
Reference price 2 26.25 50.30 55.55 38.60 27.16 25.22 25.22 25.22
Announcement Date 2/20/20 2/11/21 2/10/22 2/9/23 2/15/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 49.5 61.1 78.8 97 96.6 105 119.4 136.5
EBITDA 1 14.6 21.7 26.4 33.1 31.3 32.24 39.89 47.04
EBIT 1 12.6 17.1 23.4 29.7 27.3 28.01 35.3 42.05
Operating Margin 25.45% 27.99% 29.7% 30.62% 28.26% 26.67% 29.57% 30.8%
Earnings before Tax (EBT) 1 12.3 16.7 22.1 29.1 25.4 27.32 35.08 42.08
Net income 1 9.3 13.4 17.3 21.8 19.1 20.98 26.86 32.39
Net margin 18.79% 21.93% 21.95% 22.47% 19.77% 19.98% 22.5% 23.73%
EPS 2 0.1825 0.5040 0.6520 0.8180 0.7190 0.7883 1.009 1.214
Free Cash Flow 1 -55.8 12.8 8 21.08 4.9 23.7 28.08 32.1
FCF margin -112.73% 20.95% 10.15% 21.74% 5.07% 22.57% 23.52% 23.51%
FCF Conversion (EBITDA) - 58.99% 30.3% 63.7% 15.65% 73.52% 70.38% 68.24%
FCF Conversion (Net income) - 95.52% 46.24% 96.72% 25.65% 112.97% 104.51% 99.1%
Dividend per Share 2 0.3000 0.3200 0.3400 0.3600 0.3800 0.4000 0.4740 0.5700
Announcement Date 2/20/20 2/11/21 2/10/22 2/9/23 2/15/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 23.8 20.2 24.4 24.1 28.3 23.2 22.3 22 29.1 23.6 24.23 24.9 31.9
EBITDA 1 8.6 6.4 8 8.5 10.2 7.1 5.6 7.2 10.5 6.2 6.913 7.733 11.5
EBIT 1 7.7 5.6 7.1 7.7 9.3 6.2 4.7 6.2 9.5 5.1 5.847 6.667 10.43
Operating Margin 32.35% 27.72% 29.1% 31.95% 32.86% 26.72% 21.08% 28.18% 32.65% 21.61% 24.13% 26.77% 32.71%
Earnings before Tax (EBT) 1 7.2 5.8 7 7.6 8.6 5.8 4.4 5.9 9.2 4.8 5.667 6.567 10.33
Net income 1 5.5 4.7 5.4 6 5.7 4.2 3.2 4.5 7.2 3.6 4.43 5.077 7.773
Net margin 23.11% 23.27% 22.13% 24.9% 20.14% 18.1% 14.35% 20.45% 24.74% 15.25% 18.28% 20.39% 24.37%
EPS 2 0.2060 0.1760 0.2030 0.2260 0.2140 0.1590 0.1220 0.1680 0.2700 0.1370 0.1667 0.1900 0.2933
Dividend per Share - - - - - - - - - - - - -
Announcement Date 2/10/22 4/28/22 8/4/22 10/27/22 2/9/23 4/27/23 8/10/23 10/26/23 2/15/24 4/25/24 - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 3.8 - - - - - - -
Net Cash position 1 - 1.9 0.79 11.9 2.8 17.8 38.1 54.9
Leverage (Debt/EBITDA) 0.2603 x - - - - - - -
Free Cash Flow 1 -55.8 12.8 8 21.1 4.9 23.7 28.1 32.1
ROE (net income / shareholders' equity) 22.7% 19.9% 23.4% 25.7% 20% 19.7% 22.3% 22.8%
ROA (Net income/ Total Assets) - 14.9% 14.5% 16.7% 14% 15.1% 18.8% 18.8%
Assets 1 - 89.95 119.5 130.6 136.8 138.7 143.2 172.6
Book Value Per Share 2 2.420 2.610 2.940 3.410 3.740 4.150 4.760 5.520
Cash Flow per Share 2 0.4900 0.4600 0.8100 0.8700 - 1.160 1.250 1.300
Capex 1 68.2 2.4 13.5 2.16 4.1 4.4 4.48 5.21
Capex / Sales 137.78% 3.93% 17.13% 2.22% 4.24% 4.19% 3.75% 3.82%
Announcement Date 2/20/20 2/11/21 2/10/22 2/9/23 2/15/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
25.22 EUR
Average target price
29.32 EUR
Spread / Average Target
+16.28%
Consensus
  1. Stock Market
  2. Equities
  3. REG1V Stock
  4. Financials Revenio Group Oyj